Global Medical REIT Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Rental Revenue	144.46	138.41	140.93	137.17	115.8	93.52
Other Revenue	0.37	0.35	0.12	0.12	0.13	0.21
Total Revenue	144.83	138.76	141.05	137.28	115.94	93.73
Revenue Growth (YoY	6.04%	-1.62%	2.74%	18.41%	23.69%	32.53%
Property Expenses	0.16	0.16	0.04	0.35	0.15	6.3
Selling, General & Administrative	57.19	54.92	50.01	46.68	35.86	25.63
Depreciation & Amortization	43.02	40.43	41.27	40.01	33.83	26.75
Total Operating Expenses	110.68	105.89	103.11	98.81	78.97	65.46
Operating Income	34.15	32.87	37.94	38.47	36.97	28.28
Interest Expense	-30.92	-28.69	-30.89	-25.23	-19.7	-18.68
EBT Excluding Unusual Items	3.23	4.18	7.04	13.24	17.27	9.6
Gain (Loss) on Sale of Assets	7.62	4.21	15.56	6.75	1.07	-
Asset Writedown	-7.98	-1.7	-	-	-	-
Other Unusual Items	-0.67	-	-0.87	-	-	-12.09
Pretax Income	2.2	6.69	21.73	20	18.34	-2.5
Earnings From Continuing Operations	2.2	6.69	21.73	20	18.34	-2.5
Minority Interest in Earnings	0.3	-0.06	-1.12	-0.85	-0.72	0.57
Net Income	2.5	6.63	20.61	19.14	17.62	-1.93
Preferred Dividends & Other Adjustments	5.82	5.82	5.82	5.82	5.82	5.82
Net Income to Common	-3.32	0.81	14.79	13.32	11.8	-7.75
Net Income Growth	-43.47%	-67.82%	7.68%	8.63%	-	-
Basic Shares Outstanding	13	13	13	13	12	9
Diluted Shares Outstanding	13	13	13	13	12	9
Shares Change (YoY)	1.95%	0.59%	0.13%	7.95%	31.10%	36.59%
EPS (Basic)	-0.25	0.06	1.13	1.02	0.97	-0.84
EPS (Diluted)	-0.25	0.06	1.13	1.02	0.97	-0.84
EPS Growth	-	-94.55%	10.89%	4.57%	-	-
Dividend Per Share	3.600	4.200	4.200	4.200	4.100	4.000
Dividend Growth	-14.29%	-	-	2.44%	2.50%	-
Operating Margin	23.58%	23.69%	26.90%	28.02%	31.89%	30.17%
Profit Margin	-2.30%	0.58%	10.49%	9.70%	10.18%	-8.27%
EBITDA	87.53	84.41	91.87	91.19	80.36	62.27
EBITDA Margin	60.44%	60.83%	65.13%	66.43%	69.31%	66.43%
D&A For Ebitda	53.38	51.54	53.93	52.72	43.39	33.99
EBIT	34.15	32.87	37.94	38.47	36.97	28.28
EBIT Margin	23.58%	23.69%	26.90%	28.02%	31.89%	30.17%
Funds From Operations (FFO)	54.62	53.61	58.36	64.03	58.22	27.98
Adjusted Funds From Operations (AFFO)	-	63.36	64.31	68.04	61.36	43.94
FFO Payout Ratio	103.45%	111.68%	101.14%	91.24%	90.18%	142.75%
Revenue as Reported	144.97	138.78	141.05	137.28	115.94	93.73

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.

SEC Filings: 10-K · 10-Q